Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1P3 is a transcribed unprocessed pseudogene located on chromosome 13 that produces a long non-coding RNA (lncRNA) of 575 nucleotides[2]. Unlike its functional parent gene EEF1A1, which encodes a crucial protein translation elongation factor, EEF1A1P3 does not code for a functional protein. The pseudogene contains four non-coding exons and is classified as a transcribed unprocessed pseudogene[2]. It is expressed in various tissues including the heart (particularly the left ventricle), trachea, liver, testis, kidney, bladder, and brain, with lower expression in the adrenal gland, colon, and pituitary gland[2]. As a lncRNA, EEF1A1P3 may function in gene regulation by modulating expression at both transcriptional and post-transcriptional levels, potentially acting as a microRNA decoy, though its exact biological role remains unclear[2]. Chromosome 13, where EEF1A1P3 is located, carries several cancer-related genes including BRCA2 and RB1, suggesting potential involvement in oncogenic processes[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 3 (EEF1A1P3).